NEW YORK (GenomeWeb News) — The European Commission will spend €3 million ($3.8 million) to fund AIDS research studies that will use or develop genomics and proteomics technologies, among others, aimed at developing new HIV/AIDS treatments.
The project, which is funded under the Seventh Framework program, will support studies to develop assays and drug screening technologies, as well as research on early drug candidates with acceptable toxicity profiles.
Other research could include elucidation of 3D structures of validated targets and rational drug design guided by molecular modeling and docking of inhibitors, and validation and exploitation of the HIV-susceptible transgenic rat models to allow in vivo evaluation of novel drug candidates from the HIV-ACE program.
The project will start March 1 and run through February 2011.